[November 16, 2009] www.Xtremepicks.Com: Xtremepicks Alerts November 16, 2009 : NABI, AVGO, ECLP and MLNX Tweet (M2 PressWIRE Via Acquire Media NewsEdge) Xtremepicks.com Alerts include Nabi Biopharmaceuticals (Nasdaq: NABI), Avago Technologies (Nasdaq: AVGO), Eclipsys Corporation(R) (NASDAQ: ECLP) and Mellanox(R) Technologies, Ltd. (NASDAQ: MLNX) (TASE:MLNX) Nabi Biopharmaceuticals (Nasdaq:NABI) trading at $4.21 on a volume of 1.06M shares In a press release out on November 16, Nabi Biopharmaceuticals to Hold Conference Call ROCKVILLE, Md., Nov 16, 2009 -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will host a live webcast and conference call at 11:00 a.m. ET on Tuesday, November 17 to discuss today's announcement of the exclusive worldwide option and licensing agreement for NicVAX(R), a nicotine conjugate candidate vaccine, between GlaxoSmithKline Biologicals SA and Nabi Biopharmaceuticals. About Nabi Biopharmaceuticals Nabi Biopharmaceuticals leverages its experience and knowledge in powering the immune system to develop products that target serious medical conditions in the areas of nicotine addiction and gram-positive bacterial infections. Nabi Biopharmaceuticals is currently developing NicVAX(R) (Nicotine Conjugate Vaccine), an innovative and proprietary investigational vaccine for treatment of nicotine addiction and prevention of smoking relapse. The company is headquartered in Rockville, Maryland. For additional information about Nabi Biopharmaceuticals, please visit www.nabi.com Avago Technologies (Nasdaq:AVGO) trading at $15.65 per share on trading volume of 535 shares. In a press release out on November 16, Avago Technologies Ramps Up Production of Its QSFP+ Active Optical Cable and Transceiver Solutions Company's QSFP+ 4x10Gbps Infiniband Solutions Expands Reach While Lowering Power and Improving EMI Over Copper Interconnect Solutions PORTLAND, Ore., Nov 16, 2009 -- Avago Technologies (Nasdaq:AVGO), a leading supplier of analog interface components for communications, industrial and consumer applications, will showcase its leading QSFP+ active optical cable (AOC) and transceiver solutions for short range Infiniband and Ethernet applications this week at Supercomputing 09. Avago's AFBR-79Q4xACyyZ is a high performance integrated cable for short-range multi-lane data communication and interconnect applications. It integrates four data lanes in each direction with 40Gbps aggregate bandwidth into a single module. Each lane can operate at 10 Gbps with lengths ranging from 1 to 100 meters. About Avago Technologies Avago Technologies is a leading supplier of analog interface components for communications, industrial and consumer applications. By leveraging its core competencies in III-V compound and silicon semiconductor design and processing, the company provides an extensive range of analog, mixed signal and optoelectronics components and subsystems to approximately 40,000 end customers. Backed by strong customer service support, the company's products serve four diverse end markets: wireless communications, wired infrastructure, industrial and automotive electronics, and consumer and computing peripherals. Avago has a global employee presence and heritage of technical innovation dating back 40 years to its Hewlett-Packard roots. Information about Avago is available on the Web at www.avagotech.com Eclipsys Corporation(R) (NASDAQ: ECLP) trading at $19.93 on a volume of 60,162 shares In a press release out on November 16, Singapore General Hospital Activates Eclipsys' Sunrise Patient Flow One of World's Largest Bed Management and Radio Frequency Identification Deployments for Patient Location Tracking Occurs On Time and On Budget ATLANTA, Nov 16, 2009 -- Eclipsys Corporation(R) (NASDAQ: ECLP), The Outcomes Company(R), today announced that Singapore General Hospital (SGH), Singapore's oldest and largest acute tertiary hospital and national referral center, has successfully activated Eclipsys' Sunrise Patient Flow(TM) solution. The on-time, on-budget technology, automation and process redesign project illustrates how Eclipsys' integrated and intuitive bed management, bed turnover and patient flow system can quickly bring operational improvements to even the most complex healthcare organizations. With 1,500-beds in its acute care environment, and treating 70,000 patients annually, SGH is successfully using Sunrise Patient Flow to improve the workflows and communications of its clinical, administrative and support staff. Combined with real-time clinical visibility, the solution is yielding substantial clinical and operational advantages as it supports the goal of optimized patient throughput and efficient delivery of patient care. About Eclipsys Eclipsys is a leading provider of advanced integrated clinical, revenue cycle and performance management software, clinical content and professional services that help healthcare organizations improve clinical, financial and operational outcomes. For more information, seewww.eclipsys.com or email [email protected]. Mellanox(R) Technologies, Ltd. (NASDAQ:MLNX) (TASE:MLNX) trading at $18.70 on a volume of 52,171 shares In a press release out on November 16, Mellanox Introduces CORE-Direct, Industry's Most Advanced Application Offloading Technology for High-Performance Computing Systems ConnectX(R)-2 InfiniBand Adapters with CORE-Direct(TM) (Collectives Offload Resource Engine) Capabilities Provide Next Evolutionary Step for HPC Cluster Efficiency PORTLAND, Ore., Nov 16, 2009 -- Mellanox(R) Technologies, Ltd. (NASDAQ:MLNX) (TASE:MLNX), a leading supplier of end-to-end connectivity solutions for data center servers and storage systems, today announced the availability of ConnectX-2 adapter products with CORE-Direct, application acceleration and scaling technology. The new capabilities in ConnectX-2 mark the next evolutionary step in High-Performance Computing (HPC) interconnect solutions that will enable significant improvements in application performance and scalability, and thus increase the productivity of compute centers. About Mellanox Mellanox Technologies is a leading supplier of end-to-end connectivity solutions for servers and storage that optimize data center performance. Mellanox products deliver market-leading bandwidth, performance, scalability, power conservation and cost-effectiveness while converging multiple legacy network technologies into one future-proof solution. For the best in performance and scalability, Mellanox is the choice for Fortune 500 data centers and the world's most powerful supercomputers. Founded in 1999, Mellanox Technologies is headquartered in Sunnyvale, California and Yokneam, Israel. For more information, visit Mellanox at www.mellanox.com. Xtremepicks.com profiles early stage microcap and growth stocks that provide innovative products or services resulting in potentially "hyper-growth" opportunities. Often, these companies have yet to be recognized by Wall Street and the undiscovered nature of Xtremepicks.com's profile companies provide our members the opportunity to learn about these companies at their development stage, and more importantly before they possibly "turn the corner" and get exposed to a much larger investing audience. Xtremepicks.com (www.Xtremepicks.com) has prepared all material herein based upon information believed to be reliable. The information contained herein is not guaranteed by Xtremepicks.com to be accurate, and should not be considered to be all-inclusive. Xtremepicks.com is a leading information resource for evaluating investment opportunities in small and microcap stocks. We focus on a limited number of companies in order to provide comprehensive coverage, including unique investment related features not available anywhere else on the Internet. To feature a company or to get more information, please visit us at www.Xtremepicks.com or email us at [email protected] Xtremepicks.coms affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event of a rise in value. Xtremepicks.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. To view full disclaimers, go to http://www.Xtremepicks.com/disclaimer.htm ((Comments on this story may be sent to [email protected])) (c) 2009 M2 COMMUNICATIONS [ Back To TMCnet.com's Homepage ]